← Back to Search

Antiviral

Suboxone for Hepatitis C (PARTNERUP Trial)

N/A
Waitlist Available
Led By Mehri McKellar, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6
Awards & highlights

PARTNERUP Trial Summary

This trial will provide medication for opioid use disorder, pre-exposure prophylaxis for HIV prevention, and/or hepatitis C treatment to persons who inject opioids and access syringe services programs, using telemedicine.

Eligible Conditions
  • Hepatitis C
  • Opioid Use Disorder
  • Risk Reduction
  • HIV (Human Immunodeficiency Virus)

PARTNERUP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of medical care via a telemedicine video platform
Among participants who undergo hepatitis C treatment, the hepatitis C cure rate
Ease/difficulty of accessing the telemedicine video platform
+8 more

PARTNERUP Trial Design

1Treatment groups
Experimental Treatment
Group I: Medication and telemedicine follow upExperimental Treatment3 Interventions
Enrolled participants will be prescribed PrEP Mavyret and/or Suboxone. Follow up visits will be conducted by telemedicine. We are testing whether telemedicine is a feasible method for follow up.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Suboxone
2008
Completed Phase 3
~290
Truvada
2016
Completed Phase 4
~6920
Mavyret
2018
Completed Phase 4
~110

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,358 Previous Clinical Trials
3,420,052 Total Patients Enrolled
9 Trials studying Hepatitis C
1,859 Patients Enrolled for Hepatitis C
Center for AIDS Research (CFAR)UNKNOWN
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,268 Previous Clinical Trials
5,481,115 Total Patients Enrolled
52 Trials studying Hepatitis C
9,318 Patients Enrolled for Hepatitis C

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For what medical conditions is Mavyret commonly prescribed?

"Mavyret is frequently used to manage opioid-based ailments, yet it can also be utilized in treating other disorders such as chronic hepatitis c genotype 5 that was previously treated with an NS5A inhibitor and chronic hepatitis C genotype 1 combined with human immunodeficiency virus type 1 (HIV-1)."

Answered by AI

How many participants are researchers recruiting for this clinical trial?

"Unfortunately, no new participants are being accepted for this trial at the moment. After it's original post on February 17th 2022 and its last update during November 14th 2022, no more individuals can join in. If you're still looking to participate in medical trials related to hepatitis c or Mavyret there are currently 785 and 158 clinical studies searching for volunteers respectively."

Answered by AI

Are there vacancies for participants in this trial?

"The clinical trial, which was initially posted on February 17th 2022, is not presently enrolling patients. Nevertheless, there are 943 other medical trials actively searching for volunteers at this time according to the data available on clinicaltrials.gov."

Answered by AI

Are there any other experiments that have explored the use of Mavyret?

"Currently, 158 clinical trials are underway investigating Mavyret. Of these live experiments, 44 have reached phase 3. Although the primary research hub for this treatment is located in Boylston Massachusetts, 1906 other clinics are conducting studies related to it."

Answered by AI

Who else is applying?

What state do they live in?
North Carolina
How old are they?
18 - 65
What site did they apply to?
NC Survivors Union
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

How responsive is this trial?

Average response time
  • < 1 Day
Most responsive sites:
  1. NC Survivors Union: < 24 hours
Typically responds via
Email
Recent research and studies
clinicaltrials.govStudy
Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP
2022. "Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05108935.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top